David Copolov

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Michael Berk, David Copolov, Olivia Dean et al. · Biological Psychiatry · 2008 · 539 citations

Glutathione Precursor, N-acetyl Cysteine, Psychiatry +9

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

Michael Berk, David Copolov, Olivia Dean et al. · Biological Psychiatry · 2008 · 491 citations

N-acetyl Cysteine, Psychiatry, Mood Symptom +12

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use

Brian Dean, Suresh Sundram, Robyn Bradbury et al. · Neuroscience · 2001 · 385 citations

Cannabis Use, Psychoactive Drug, Psychiatry +14

Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients

Suzie Lavoie, Micah M. Murray, Patricia Deppen et al. · Neuropsychopharmacology · 2007 · 371 citations · Full text

Glutathione Precursor, Psychiatry, Schizophrenia +3

Hippocampal Volume in First-Episode Psychoses and Chronic Schizophrenia

Dennis Velakoulis, Christos Pantelis, Patrick D. McGorry et al. · Archives of General Psychiatry · 1999 · 362 citations